Non-Invasive Spinal Cord Stimulation for Neurological Disorders
Trial Summary
What is the purpose of this trial?
The purpose of the study is to evaluate whether non-invasive stimulation over the spinal cord at the neck and/or lower back can improve walking function for people with neurologic conditions. Spinal stimulation has been used extensively for individuals with spinal cord injury, and has demonstrated improvements in function. This study will extend this work to other neurologic conditions, such as cerebral palsy and stroke, that also demonstrate similar impairments as spinal cord injury. The primary aims of this study are to: Aim 1: Evaluate impact of spinal stimulation on spasticity and locomotor function. Aim 2: Investigate participant perceptions of spinal stimulation. The investigators will be using a cross-over design study to compare intensive training only to intensive training combined with spinal stimulation. After an initial baseline period of up to 4 weeks (Phase I). Participants will have their first intervention phase of the study (Phase II). This will involve either intensive training only (Condition A) or intensive training combined with spinal stimulation (Condition B). This will be followed by a washout period with no intervention (Phase III) and then the second intervention phase (Phase IV). The second intervention phase will involve either Condition A or Condition B, whichever the participants did not received during Phase II. Phases II-IV will each last up to 8 weeks. After the intervention period is complete, the participant will be asked to come for follow-up visits up to 3 months after the intervention phases are completed (Phase V).
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have an implanted stimulator or drug delivery device, you cannot participate in the trial.
What data supports the effectiveness of the treatment Non-Invasive Spinal Cord Stimulation for Neurological Disorders?
Research shows that combining locomotor training with transcutaneous spinal stimulation (TSS) can improve walking speed and distance in people with spinal cord injuries. Although improvements in spasticity (muscle stiffness) were not significant, TSS is a feasible addition to enhance walking outcomes during rehabilitation.12345
Is non-invasive spinal cord stimulation safe for humans?
Research suggests that non-invasive spinal cord stimulation, often combined with locomotor training, is generally safe for humans. Studies have shown it to be a feasible treatment option with no significant adverse effects reported, making it a promising approach for improving motor functions in conditions like spinal cord injury and cerebral palsy.16789
How is Gait Training different from other treatments for neurological disorders?
Gait Training, combined with non-invasive spinal cord stimulation, is unique because it uses painless electrical stimulation to modulate the spinal cord's neural circuits, enhancing stepping movements and motor control without the need for invasive procedures. This approach can improve locomotor function even in individuals with severe spinal cord injuries, offering a novel way to rehabilitate sensorimotor function.910111213
Research Team
Katherine M Steele, PhD
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for people with neurological conditions like cerebral palsy who can walk 20 yards and follow simple instructions. They must be medically stable, able to attend up to five therapy sessions weekly, and have support for the 11-month study period. Those with severe medical issues, uncontrolled seizures, recent musculoskeletal surgeries, or implanted devices are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Initial baseline period to assess participants before intervention
First Intervention
Participants undergo either intensive training only or intensive training combined with spinal stimulation
Washout
A period with no intervention to eliminate effects of the first intervention
Second Intervention
Participants undergo the intervention they did not receive during the first intervention phase
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Gait Training
- Transcutaneous Spinal Stimulation
Gait Training is already approved in United States, European Union, Canada for the following indications:
- Spinal Cord Injury
- Cerebral Palsy
- Stroke Rehabilitation
- Spinal Cord Injury
- Neurological Rehabilitation
- Spinal Cord Injury
- Stroke Rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
Seattle Children's Hospital
Collaborator